Effectiveness of carvedilol alone versus carvedilol plus pimobendan for severe congestive heart failure

被引：29

作者：

Yoshikawa, T ^{[1
]}

Baba, A ^{[1
]}

Suzuki, M ^{[1
]}

Yokozuka, H ^{[1
]}

Okada, Y ^{[1
]}

Nagami, K ^{[1
]}

Takahashi, T ^{[1
]}

Mitamura, H ^{[1
]}

Ogawa, S ^{[1
]}

机构：

[1] Keio Univ, Sch Med, Dept Med, Div Cardiol,Shinjuku Ku, Tokyo 1608582, Japan

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2000年 / 85卷 / 12期

关键词：

D O I：

10.1016/S0002-9149(00)00803-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We attempted to characterize the role of short-term coadministration of pimobendan in beta-blocker therapy for severe congestive heart failure in 30 patients in a randomized fashion. Results suggested that short-term coadministration of pimobendan with the introduction of carvedilol therapy was safe and had favorable effects on neurohormone levels in patients with severe congestive heart failure.

引用

页码：1495 / +

页数：4

共 16 条

[1] CONTRIBUTION OF CAMP-PHOSPHODIESTERASE INHIBITION AND SENSITIZATION OF THE CONTRACTILE PROTEINS FOR CALCIUM TO THE INOTROPIC EFFECT OF PIMOBENDAN IN THE FAILING HUMAN MYOCARDIUM [J].

BOHM, M ;

MORANO, I ;

PIESKE, B ;

RUEGG, JC ;

WANKERL, M ;

ZIMMERMANN, R ;

ERDMANN, E .

CIRCULATION RESEARCH, 1991, 68 (03) :689-701

[2] Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure [J].

Bristow, MR ;

Gilbert, EM ;

Abraham, WT ;

Adams, KF ;

Fowler, MB ;

Hershberger, RE ;

Kubo, SH ;

Narahara, KA ;

Ingersoll, H ;

Krueger, S ;

Young, S ;

Shusterman, N .

CIRCULATION, 1996, 94 (11) :2807-2816

[3] DOSE-RESPONSE OF CHRONIC BETA-BLOCKER TREATMENT IN HEART-FAILURE FROM EITHER IDIOPATHIC DILATED OR ISCHEMIC CARDIOMYOPATHY [J].

BRISTOW, MR ;

OCONNELL, JB ;

GILBERT, EM ;

FRENCH, WJ ;

LEATHERMAN, G ;

KANTROWITZ, NE ;

ORIE, J ;

SMUCKER, ML ;

MARSHALL, G ;

KELLY, P ;

DEITCHMAN, D ;

ANDERSON, JL .

CIRCULATION, 1994, 89 (04) :1632-1642

[4] SENSITIZATION OF DOG AND GUINEA-PIG HEART MYOFILAMENTS TO CA2+ ACTIVATION AND THE INOTROPIC EFFECT OF PIMOBENDAN - COMPARISON WITH MILRINONE [J].

FUJINO, K ;

SPERELAKIS, N ;

SOLARO, RJ .

CIRCULATION RESEARCH, 1988, 63 (05) :911-922

[5] INFLUENCE OF UDCG-115 ON HEMODYNAMICS AND MYOCARDIAL ENERGETICS IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY [J].

HASENFUSS, G ;

HOLUBARSCH, C ;

HEISS, HW ;

JUST, H .

AMERICAN HEART JOURNAL, 1989, 118 (03) :512-519

[6] DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE LONG-TERM EFFICACY OF CARVEDILOL IN PATIENTS WITH SEVERE CHRONIC HEART-FAILURE [J].

KRUM, H ;

SACKNERBERNSTEIN, JD ;

GOLDSMITH, RL ;

KUKIN, ML ;

SCHWARTZ, B ;

PENN, J ;

MEDINA, N ;

YUSHAK, M ;

HORN, E ;

KATZ, SD ;

LEVIN, HR ;

NEUBERG, GW ;

DELONG, G ;

PACKER, M .

CIRCULATION, 1995, 92 (06) :1499-1506

[7]

Lechat P, 1999, LANCET, V353, P9

[8] A RANDOMIZED TRIAL OF BETA-BLOCKADE IN HEART-FAILURE - THE CARDIAC-INSUFFICIENCY BISOPROLOL STUDY (CIBIS) [J].

LECHAT, P ;

JAILLON, P ;

FONTAINE, ML ;

CHANTON, E ;

MESENGE, C ;

GAGEY, S ;

GUILLARDEAU, A ;

DUSSOUS, V .

CIRCULATION, 1994, 90 (04) :1765-1773

[9] Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure [J].

Macdonald, PS ;

Keogh, AM ;

Aboyoun, CL ;

Lund, M ;

Amor, R ;

McCaffrey, DJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (04) :924-931

[10]

*MERIT HF STUD GRO, 1999, LANCET, V353, P2110

← 1 2 →